⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6897683 | 0.78 | — | — | |
| SCHEMBL8429764 | 0.77 | — | — | |
| SCHEMBL3321079 | 0.75 | — | — | |
| SCHEMBL157962 | 0.75 | — | — | |
| SCHEMBL7118357 | 0.75 | — | — | |
| SCHEMBL33790 | 0.75 | — | — | |
| SCHEMBL11346226 | 0.72 | — | — | |
| SCHEMBL17744967 | 0.71 | — | — | |
| SCHEMBL6381754 | 0.68 | — | — | |
| SCHEMBL324755 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116162674-B | Preparation method of 6-hydroxy-flavin adenine dinucleotide and application of 6-hydroxy-flavin adenine dinucleotide as iron death inhibitor | 山东大学 | 2025-01-28 | — | — | CN | disclosed |
| CN-118119404-A | Immunogenic LNP compositions and methods thereof | 辉瑞公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-117597144-A | Immunogenic compositions against influenza | 辉瑞公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-116782889-A | Enhanced formulation stability and improved lyophilization process | 生物技术欧洲股份公司 | 2023-09-19 | — | — | CN | disclosed |
| US-10745728-B1 | Applications for biversal nucleoside analogs | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-08-18 | — | — | US | disclosed |
| US-20070032442-A1 | Vector utilizing ribonuclease reductase UTR and use for inhibiting neoplastic cells | GENESENSE TECHNOLOGIES INC. (CA) | 2007-02-08 | — | — | US | disclosed |